Key result
Strict nonpharmaceutical interventions fail to reduce asymptomatic rhinovirus infections.
Why the study?
Asymptomatic rhinovirus infections in adults require further investigation, particularly because rhinovirus circulation persisted despite COVID-19 nonpharmaceutical interventions that reduced other respiratory viruses.
Do nonpharmaceutical interventions for COVID-19 mitigate asymptomatic and symptomatic rhinovirus infections in adults?
Cross-Sectional (n=89,571)
No
Do nonpharmaceutical interventions for COVID-19 mitigate asymptomatic and symptomatic rhinovirus infections in adults?
Persistent asymptomatic rhinovirus infections in young and middle-aged adults were unaffected by strict nonpharmaceutical interventions for COVID-19.
Answers are grounded in this paper and cite their sources.
Asymptomatic RV during NPIs questions broad effectiveness; leaves open adult transmission dynamics and causal effects.
Background Rhinovirus (RV) is a common respiratory virus, but asymptomatic RV infections in adults still require further investigation. Nonpharmaceutical interventions (NPIs) for COVID‐19 markedly reduced other respiratory viruses, yet RV circulation appeared to persist. We describe the epidemiology of asymptomatic and symptomatic adult RV infections in Shanghai across periods with and without strict NPIs. Methods We performed a retrospective, hospital‐based repeated cross‐sectional study at a large hospital in Shanghai over two epidemic cycles (March 2021 to February 2022 and June 2023 to May 2024). Adults undergoing routine SARS‐CoV‐2 screening (asymptomatic group) and hospitalized adults with respiratory symptoms (symptomatic group) were systematically sampled. Nasopharyngeal swabs were tested by RT‐PCR, and RV‐positive samples underwent genotyping and quantitative viral load assessment. Clinical characteristics, co‐/secondary infections, and age‐specific patterns were compared using χ 2 tests and nonparametric tests, and associations between RV prevalence and climate variables were evaluated using correlation analysis. Results Among 89,571 adults, 865 RV infections were identified. Asymptomatic RV detection remained low and similar during and after strict NPIs (0.68% vs. 0.56%). Adults aged 18–59 years had higher asymptomatic infection rates than those ≥ 60 years (0.68% vs. 0.55%, p = 0.022). RV‐A predominated, while RV‐C was associated with higher viral loads and more frequent symptoms. Total monthly rainfall showed the strongest negative correlation with asymptomatic RV prevalence ( r = −0.418, p = 0.042). Symptomatic cases had higher co‐infection rates. Conclusions Persistent asymptomatic RV infections in young and middle‐aged adults were unaffected by NPIs. Older adults were more often symptomatic and experienced more frequent co‐infections.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) conducted a cross-sectional in Rhinovirus (RV) infections (n=89,571). Strict nonpharmaceutical interventions (NPIs) vs. Periods without strict NPIs was evaluated on Asymptomatic RV detection rate. Strict nonpharmaceutical interventions did not mitigate asymptomatic rhinovirus infections, with detection rates remaining similar during and after NPI periods (0.68% vs. 0.56%).
Synapse has enriched 10 related papers. Consider them for comparative context: